In almost all cases where nanoparticles have shown promise to treat various conditions, there remains one huge hurdle: how do you get them into the patient? i.e. Swallow a pill full of nanoparticles, and later that day you'll end up taking a nanoparticle-filled dump. Oral bioavailability is almost nonexistent. The only practical delivery mechanism is IV. For treating cancer, that's fine. Most advanced chemotherapy drugs already are delivered via IV. For an antibiotic, which will see greatest demand in locations with poor health facilities, i.e. with no real means of safely delivering IV drugs to large numbers of people, that's pretty much a deal breaker.
Well, that doesn't really have a lot of confidence behind it.
Bacteria can do thousands or millions of generations more rapidly than we can tweak our nanotech.
That is, anything that can live in a 40+% alcohol environment is also not going to find the human body hospitable.
Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers https://www.nature.com/articles/nmicrobiol2016162
An article for non-expert: http://www.telegraph.co.uk/health-fitness/body/does-this-25-...
"Lam successfully tested the polymer treatment on six different superbugs in the laboratory, and against one strain of bacteria in mice. Even after multiple generations of mutations, the superbugs have proven incapable of fighting back.
“We found the polymers to be really good at wiping out bacterial infections,” she says. “They are actually effective in treating mice infected by antibiotic-resistant bacteria. At the same time, they are quite non-toxic to the healthy cells in the body.”"
"Professor Greg Qiao, her PhD supervisor, says that Lam’s project is one of the biggest scientific breakthroughs he had seen in his 20 years at Melbourne university."